Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to Twist. [electronic resource]
Producer: 20191206Description: 709-722 p. digitalISSN:- 1470-8736
- A549 Cells
- Animals
- Antineoplastic Agents -- pharmacology
- Cell Movement -- drug effects
- Epithelial-Mesenchymal Transition -- drug effects
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Gene Expression Regulation, Neoplastic
- Humans
- Liver Neoplasms -- genetics
- Lung Neoplasms -- drug therapy
- Male
- Melatonin -- pharmacology
- Mice, SCID
- Neoplasm Invasiveness
- Nuclear Proteins -- genetics
- Phosphorylation
- Receptor, Melatonin, MT1 -- agonists
- Signal Transduction
- Twist-Related Protein 1 -- genetics
- Type C Phospholipases -- metabolism
- Xenograft Model Antitumor Assays
- beta Catenin -- metabolism
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.